NORRIS MEDICINES LTD. Share Price

BSE: 524414

S Cap

₹ 16.05

-₹0.26 (-1.59%)

Last updated 14 Aug, 2026, 11:19 IST

NORRIS MEDICINES LTD. Share Price Today

As of 14 Aug 2026, NORRIS MEDICINES LTD. share price is ₹16.05. The stock opened at ₹16.05, compared to its previous close of ₹16.31. During today's trading session, NORRIS MEDICINES LTD. share price moved in the range of ₹16.05 to ₹17.05, with an average price of ₹16.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹12.00 and a high of ₹19.63.

₹16.05

1.59% down today

₹17.05

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 12.92 % in last 3 month

NORRIS MEDICINES LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,64,948-₹35,052 (-7.01%)

3 Year

₹6,59,408+₹1,59,408 (+31.88%)

5 Year

₹8,73,232+₹3,73,232 (+74.65%)

₹15.50₹17.12

Circuit Low

Circuit High

₹12.00₹19.63

52-Week Low

52-Week High

Circuit

₹15.50

₹17.12

52-week

₹12.00

₹19.63

About NORRIS MEDICINES LTD.

ISIN

INE744C01029

Sector Market Cap

₹ 16.31 Cr

Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatological range, nutrition range, anti-malaria, anti-emetic, cough/cold range, dental range, diabetics and cardiac, and miscellaneous range. Its antibiotic products include Arizon-100, Arizon-250, Arizon-500, Cefan-dry syurp, and Cefan DT-50. Its G.I. products include Denzym Syrup, Denzym Oral Drop, Ezynor-20, Regus-DSR, Sucrinor and Rinotac. Its dermatological products include Clobec-G, Gabax, Morfit Plus, Novadin-M, Silwon-C and Tioderm. Its nutrition products include Cand XP, Cand Fort, Can D suspension and Hemfit Plus Syrup. It has two plants situated at GIDC, Ankleshwar, Gujarat. Both the plants of the Company are World Health Organization Good Manufacturing Practices (WHO GMP) approved.

NORRIS MEDICINES LTD. Financial Highlights

Revenue: NORRIS MEDICINES LTD. reported revenue of ₹8.18 crore in FY26 vs ₹5.88 crore in FY25. It showed an increase of 39.12% on a yearly basis.
Operating Profit: NORRIS MEDICINES LTD. reported an operating loss of ₹0.28 crore in FY26 vs ₹1.18 crore in FY25. It showed an increase of 76.27% on a year-on-year basis.
Net Profit: NORRIS MEDICINES LTD. reported a net loss of ₹0.28 crore in FY26 vs ₹1.24 crore in FY25. It showed an increase of 77.42% on a yearly basis.

NORRIS MEDICINES LTD. Quarterly Result Highlights

NORRIS MEDICINES LTD. reported revenue of ₹1.43 crore in Mar 2026, compared with ₹3.27 crore in Dec 2025, representing a decrease of 56.27% on a quarter-on-quarter (QoQ) basis.
NORRIS MEDICINES LTD. reported an operating profit of ₹0.05 crore in Mar 2026, compared with ₹0.70 crore in Dec 2025, representing a decrease of 92.86% on a quarter-on-quarter (QoQ) basis.
NORRIS MEDICINES LTD. reported a profit of ₹0.05 crore in Mar 2026, compared with ₹0.70 crore in Dec 2025, reflecting a decrease of 92.86% on a QoQ basis.
The earnings per share (EPS) of NORRIS MEDICINES LTD. stood at ₹1.24 during Mar 2026.

Know more

Promoters

34.01%

FII

0.00%

Other DII

0.06%

Retail and other

65.92%

Mutual funds

0.01%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

16.31

P/E

-58.25

P/B

0.00

ROE

1.85%

D/E

-1.42

ROCE

3.44%

Div. Yield

0.00%

EPS(TTM)

-0.28

Turnover

2.42

EV/EBITDA

53.19

Net Margin

0.00%

Op. Margin

0.00%

ROA

-2.17%

Quick Ratio

0.00

Curr. Ratio

0.89

Mkt Cap Cr

16.31

P/E

-58.25

P/B

0.00

ROE

1.85%

D/E

-1.42

ROCE

3.44%

Div. Yield

0.00%

EPS(TTM)

-0.28

Turnover

2.42

EV/EBITDA

53.19

Net Margin

0.00%

Op. Margin

0.00%

ROA

-2.17%

Quick Ratio

0.00

Curr. Ratio

0.89

Based on fundamentals, this stock's

Performance

Very Poor

Norris Medicines has not beaten FD return of 7%

Valuation

Overvalued

Norris Medicines appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,66,155.00	38.47	5.58	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,25,648.00	77.15	13.46	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,86,000.00	86.03	22.06	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,17,007.00	25.48	4.32	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,18,027.00	35.17	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,549.00	18.62	4.61	23.76%	0.04	24.88%	659.05	0.80%	0.57	129.18
Mankind Pharma	1,00,137.00	48.30	6.13	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,662.00	31.62	2.64	11.07%	0.18	12.54%	377.96	0.66%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,215.60	26.06	2.55	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

NORRIS MEDICINES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹5.82	₹5.64	₹8.36	₹9.44
Other Income	₹0.06	₹0.03	₹0.01	₹0.03
Total Revenue	₹5.88	₹5.66	₹8.37	₹9.46
Total Expenses	₹7.06	₹6.76	₹9.57	₹11.65
Profit Before Tax	-₹1.18	-₹1.10	-₹1.19	-₹2.18
Tax	₹0.06	₹0.09	₹0.56	₹1.08
Profit After Tax	-₹1.24	-₹1.19	-₹1.75	-₹3.26
EPS - Basic	-₹1.24	-₹1.19	-₹1.75	-₹3.26
EPS - Diluted	-₹1.24	-₹1.19	-₹1.75	-₹3.26

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹1.24	-₹1.19	-₹1.75	-₹3.26
Income before WC changes	-₹0.22	-₹0.15	₹0.92	-₹0.06
Change in Assets	-₹0.19	-₹1.20	-₹0.65	₹3.96
Change in Liabilities	₹0.92	₹1.52	₹0.92	-₹4.91
Change in WC	₹0.73	₹0.32	₹0.27	-₹0.95
Cash flow from Operations	₹0.51	₹0.17	₹1.20	-₹1.01
Cash flow from Investing	₹0.00	₹0.05	-₹0.02	-₹0.09
Cash flow from Financing	-₹0.50	-₹0.20	-₹1.18	₹1.10
Total Cash Flow	₹0.00	₹0.02	₹0.00	₹0.00
Cash (Start of the year)	₹0.04	₹0.02	₹0.02	₹0.02
Cash (End of the year)	₹0.04	₹0.04	₹0.02	₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹7.47	₹8.04	₹8.77	₹9.92
Current Assets	₹6.34	₹6.14	₹4.92	₹4.27
Total Assets	₹13.81	₹14.19	₹13.69	₹14.19
Current Liabilities	₹10.15	₹9.23	₹7.70	₹6.78
Net Current Asset	-₹3.81	-₹3.08	-₹2.78	-₹2.51
Non-Current Liabilities	₹18.53	₹18.59	₹18.43	₹18.10
Equity Capital	-₹14.87	-₹13.63	-₹12.44	-₹10.69
Total Equity & Liabilities	₹13.81	₹14.19	₹13.69	₹14.19